Cleared Traditional

K213778 - IV Administration Set

K213778 is an FDA 510(k) clearance for IV Administration Set, manufactured by B.Braun Medical, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 90-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2022
Decision
90d
Days
Class 2
Risk

K213778 is an FDA 510(k) clearance for the IV Administration Set. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by B.Braun Medical, Inc. (Allentown, US). The FDA issued a Cleared decision on March 3, 2022 after a review of 90 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all B.Braun Medical, Inc. devices

FDA 510(k) Submission Details - K213778

510(k) Number K213778 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 03, 2021
Decision Date March 03, 2022
Days to Decision 90 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 129d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 769
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K213778.
Q2 IV Administration Sets
K213588 · Quest Medical, Inc. · Jun 2022
Needle Free Connector
K213004 · Medcaptain Life Science Co., Ltd. · May 2022
Infusion Sets for Single Use
K202437 · Jiangsu Suyun Medical Materials Co., Ltd. · Mar 2022
Microvolume Luer Access Device
K212842 · B.Braun Medical, Inc. · Jan 2022
Ivenix Infusion System, LVP Epidural Administraion Set NRFit Connector
K213089 · Ivenix, Inc. · Nov 2021
Intravascular Administration Sets
K203609 · Baxter Healthcare Corporation · Sep 2021